Global Legal Cannabis for Medical Use Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Legal Cannabis for Medical Use Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Legal Cannabis for Medical Use report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Legal Cannabis for Medical Use market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Cancer and Arthritis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Legal Cannabis for Medical Use industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Legal Cannabis for Medical Use key manufacturers include BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc, Canopy Growth Corporation, Insys Therapeutics, Inc, Aphria, Inc, MGC Pharmaceuticals Limited and GW Pharmaceuticals, plc, etc. BOL Pharma, Tilray, Medreleaf Corporation are top 3 players and held % sales share in total in 2022.
Legal Cannabis for Medical Use can be divided into Tetrahydrocannabinol (THC) and Cannabidiol (CBD), etc. Tetrahydrocannabinol (THC) is the mainstream product in the market, accounting for % sales share globally in 2022.
Legal Cannabis for Medical Use is widely used in various fields, such as Cancer, Arthritis, Migraine and Epilepsy, etc. Cancer provides greatest supports to the Legal Cannabis for Medical Use industry development. In 2022, global % sales of Legal Cannabis for Medical Use went into Cancer filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Legal Cannabis for Medical Use market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
BOL Pharma
Tilray
Medreleaf Corporation
Aurora Cannabis, Inc
Canopy Growth Corporation
Insys Therapeutics, Inc
Aphria, Inc
MGC Pharmaceuticals Limited
GW Pharmaceuticals, plc
Medical Marijuana Inc
Medipharm Labs
Segment by Type
Tetrahydrocannabinol (THC)
Cannabidiol (CBD)
Cancer
Arthritis
Migraine
Epilepsy
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Legal Cannabis for Medical Use market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Legal Cannabis for Medical Use, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Legal Cannabis for Medical Use industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Legal Cannabis for Medical Use in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Legal Cannabis for Medical Use introduction, etc. Legal Cannabis for Medical Use Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Legal Cannabis for Medical Use market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
North America, Europe and Asia Pacific are the key regions for Legal Cannabis for Medical Use industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Legal Cannabis for Medical Use key manufacturers include BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc, Canopy Growth Corporation, Insys Therapeutics, Inc, Aphria, Inc, MGC Pharmaceuticals Limited and GW Pharmaceuticals, plc, etc. BOL Pharma, Tilray, Medreleaf Corporation are top 3 players and held % sales share in total in 2022.
Legal Cannabis for Medical Use can be divided into Tetrahydrocannabinol (THC) and Cannabidiol (CBD), etc. Tetrahydrocannabinol (THC) is the mainstream product in the market, accounting for % sales share globally in 2022.
Legal Cannabis for Medical Use is widely used in various fields, such as Cancer, Arthritis, Migraine and Epilepsy, etc. Cancer provides greatest supports to the Legal Cannabis for Medical Use industry development. In 2022, global % sales of Legal Cannabis for Medical Use went into Cancer filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Legal Cannabis for Medical Use market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
BOL Pharma
Tilray
Medreleaf Corporation
Aurora Cannabis, Inc
Canopy Growth Corporation
Insys Therapeutics, Inc
Aphria, Inc
MGC Pharmaceuticals Limited
GW Pharmaceuticals, plc
Medical Marijuana Inc
Medipharm Labs
Segment by Type
Tetrahydrocannabinol (THC)
Cannabidiol (CBD)
Segment by Application
Cancer
Arthritis
Migraine
Epilepsy
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Legal Cannabis for Medical Use market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Legal Cannabis for Medical Use, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Legal Cannabis for Medical Use industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Legal Cannabis for Medical Use in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Legal Cannabis for Medical Use introduction, etc. Legal Cannabis for Medical Use Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Legal Cannabis for Medical Use market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices